Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.
about
Development and external validation of a prognostic nomogram for metastatic uveal melanomaMetastatic disease from uveal melanoma: treatment options and future prospectsUveal Melanoma: Current Trends in Diagnosis and ManagementPhase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanomaUveal melanoma: epidemiology, etiology, and treatment of primary disease.Uveal melanoma: From diagnosis to treatment and the science in between.MuSIC report III: tumour microcirculation patterns and development of metastasis in long-term follow-up of melanocytic uveal tumours.Management of uveal melanoma: a consensus-based provincial clinical practice guidelineDual-energy CT of liver metastases in patients with uveal melanoma.The biology of uveal melanomaMaking the Case: Intra-arterial Therapy for Less Common Metastases.Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion.Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.Recent advances in uveal melanoma treatment.Treatment of uveal melanoma: where are we now?The Interdisciplinary Diagnosis and Treatment of Intraocular Tumors.Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications.
P2860
Q21131800-79D1B210-39AB-4BB0-B1DF-980A5D8E82BEQ26738377-94A1D7FD-AD1C-4475-B3BF-D1C2AFE22FCAQ28073924-05D4A7BF-7FEA-4B0A-ADFC-7D09D0F36090Q28543960-BBE25ADF-C80E-4BBE-BB1C-ECFE528A1C4CQ30235934-EA2EDE0E-357D-410F-9B8D-0EFF64D7DBF8Q30251762-3A358499-C466-41EE-9ABE-7AF41A0CC328Q30379803-164A5EF9-7843-4DA2-9A56-2DA549EBF223Q30388575-AF523FC9-748D-48AF-93CC-E17FEACD8259Q37392038-8D9CEC4D-0072-479F-B7E7-A63380C5B5B9Q37742632-5CADE56D-95E5-44AB-BCB9-1E4207CD12EAQ38745186-87A6B8F4-57ED-4905-873A-C7FB67417057Q38783820-9CBB1DF0-3D24-45F6-9BC5-A7AEBA1E93C1Q40251215-36F0AF17-650D-45A5-B3D5-6D8DA380DE5DQ43181572-69E7AB1C-69E4-443A-8352-C3A4AB10958BQ47571643-181AC033-7F4E-48DB-819F-E614C0102F91Q50349181-0646CCBB-8968-4576-8A51-0AF857234913Q52671305-C491F8D5-BFE6-41F3-8F45-B45DAA5BC3F5Q53017847-DF6A81FD-873F-4591-91C2-35FBE2C0A8A4
P2860
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hepatic intra-arterial versus ...... multicentric randomized trial.
@ast
Hepatic intra-arterial versus ...... multicentric randomized trial.
@en
type
label
Hepatic intra-arterial versus ...... multicentric randomized trial.
@ast
Hepatic intra-arterial versus ...... multicentric randomized trial.
@en
prefLabel
Hepatic intra-arterial versus ...... multicentric randomized trial.
@ast
Hepatic intra-arterial versus ...... multicentric randomized trial.
@en
P2093
P2860
P356
P1433
P1476
Hepatic intra-arterial versus ...... multicentric randomized trial.
@en
P2093
D Schadendorf
E Kaempgen
E Marshall
J B Vermorken
J F Baurain
M Scheulen
M Zdzienicki
R Karra Gurunath
P2860
P304
P356
10.1093/ANNONC/MDT585
P577
2014-02-07T00:00:00Z